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Children with Down syndrome (DS) use hospital services more often than children without DS, 
but data on racial/ethnic variations are limited. This study generated population-based estimates of 
hospital use and cost to 3 years of age by race/ethnicity among children with DS in Massachusetts 
using birth certificates linked to birth defects registry and hospital discharge data from 1999 to 
2004. Hospital use (≥1 post-birth hospitalization and median days hospitalized birth and post-
birth) and reasons for hospitalization were compared across maternal race/ethnicity using relative 
risk (RR) and Wilcoxon rank sums tests, as appropriate. Costs were calculated in 2011 United 
States dollars. Greater hospital use was observed among children with DS with Hispanic vs. Non-
Hispanic White (NHW) mothers (post-birth hospitalization: RR 1.4; median days hospitalized: 
20.0 vs. 11.0, respectively). Children with DS and congenital heart defects of Non-Hispanic Black 
(NHB) mothers had significantly greater median days hospitalized than their NHW counterparts 
(24.0 vs. 16.0, respectively). Respiratory diagnoses were listed more often among children with 
Hispanic vs. NHW mothers (50.0% vs. 29.1%, respectively), and NHBs had more cardiac 
diagnoses (34.1% vs. 21.5%, respectively). The mean total hospital cost was nine times higher 
among children with DS ($40,075) than among children without DS ($4053), and total costs 
attributable to DS were almost $18 million. Median costs were $22,781 for Hispanics, $18,495 for 
NHBs, and $13,947 for NHWs. Public health interventions should address the higher rates of 
hospital use and hospitalizations for respiratory and cardiac diseases among racial/ethnic minority 
children with DS in Massachusetts.
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1. Introduction
Down syndrome (DS) affects more than one in 1000 live births in the United States (US), 
with high rates of neonatal comorbidities and hospital use and related costs in the first years 
of life in comparison to children without DS (Boulet, Molinari, Grosse, Honein, & Correa, 
2008; Centers for Disease Control and Prevention, 2007; Cleves et al., 2007; Rasmussen, 
Whitehead, Collier, & Frías, 2008; So et al., 2007; Torfs & Christianson, 1998). 
Documented improvements in survival for children with DS (Centers for Disease Control 
and Prevention, 2001; Rasmussen, Wong, Correa, Gambrell, & Friedman, 2006; Yang, 
Rasmussen, & Friedman, 2002) mean that the number of children growing up with DS is 
increasing as are the need and demand for specialized health services for people with DS. 
Consequently, there is a need for more current information on the extent and cost 
implications of health service needs.
Persistent, unexplained racial/ethnic disparities in survival for children with DS favoring 
Non-Hispanic Whites (NHWs) over Non-Hispanic Blacks (NHBs; Centers for Disease 
Control and Prevention, 2001; Rasmussen et al., 2006; Yang et al., 2002), raise questions 
about the potential contributions of differences in access to and use of health services to 
disparities in health outcomes. However, published studies examining possible racial/ethnic 
variations in these factors among children with DS have been limited. In contrast, numerous 
studies have documented racial/ethnic differences in preventable hospitalizations for other 
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chronic conditions such as asthma (e.g., Ash & Brandt, 2006; Crocker et al., 2009; Erickson, 
Iribarren, Tolstykh, Blanc, & Eisner, 2007; Jones, Lin, Munsie, Radigan, & Hwang, 2008; 
Laditka & Laditka, 2006; Lu & Kuo, 2012; Roy, McGinty, Hayes, & Zhang, 2010).
Information on hospital use and cost is important for deliberations on cost-effective 
approaches for providing health services to a growing population of children, adolescents, 
and adults with DS. Recent US-based studies (Boulet et al., 2008; Centers for Disease 
Control and Prevention, 2007; Russo & Elixhauser, 2007; So et al., 2007) have provided 
some of this information. However, such studies used hospital administrative databases in 
which ascertainment of DS and co-occurring birth defects was based on International 
Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis 
codes alone, a method that is less accurate compared to active case ascertainment methods 
used in several state birth defects registries (Frohnert et al., 2005). The generalizability of 
the findings reported by Boulet and colleagues (2008) is further limited because it was based 
on a privately insured sample. Moreover, comparisons of hospital use and cost among 
privately insured children with DS to those with other types of insurance would generate 
useful data on the cost-effectiveness of alternative approaches to health care coverage. The 
study by Russo and Elixhauser (2007) generated data on rates of use or cost per hospital 
visit, not per individual with DS, and the study by the Centers for Disease Control and 
Prevention (CDC, 2007) was limited to hospitalizations of children under 10 days old and 
excluded birth hospitalization costs. Data on costs per individual for longer periods of time 
are needed to estimate the potential benefits and cost-savings of prevention interventions.
Population-based research using linked data systems that include birth defects registries 
could improve existing information on the extent to which children with DS in the US use 
hospital-related services, the reasons for and costs of those hospitalizations, how other 
characteristics impact use and cost, and, importantly, how differential use and cost may be 
related to racial/ethnic disparities in morbidity and mortality. This study used such a data 
system in Massachusetts to address three questions: (1) Do patterns of hospital use from 
birth to age three among children with DS differ from those among children without DS by 
maternal race/ethnicity, delivery payer source, and presence of other comorbidities; (2) 
Among children with DS, are there differences in patterns of hospital use by race/ethnicity; 
and (3) Do racial/ethnic differences in hospital use and cost among children with DS 
correspond to previously reported racial/ethnic disparities in survival?
2. Material and methods
2.1. Data source
Data came from the population-based Massachusetts Pregnancy to Early Life Longitudinal 
(PELL) Data System. PELL consists of a core linkage, performed as described elsewhere 
(Declercq et al., 2007; Weiss et al., 2009), between birth certificates and infant/maternal 
birth/delivery hospital records (core linkage rate 99.5%) that is then longitudinally linked to 
birth defects registry data from the Massachusetts Birth Defects Monitoring Program 
(MBDMP), death certificates, and hospital discharge records for post-birth hospital stays (as 
well as other databases not used in this study). The MBDMP ascertains major birth defects 
among all live births to age one year by using active surveillance methods (Lynberg & 
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Edmonds, 1992). The longitudinal linkage rate was 82.0% for post-birth inpatient hospital 
admissions of Massachusetts resident children under three years of age born from 1998 to 
2008 (specific data on the 1999–2004 study population are not available; see Section 2.2). 
This study was approved by the Institutional Review Boards of the Massachusetts 
Department of Public Health and Boston University Medical Center.
2.2. Study population
The study population was defined as children born alive between January 1, 1999 and 
December 31, 2004 to Massachusetts resident mothers in a Massachusetts maternity hospital 
with a core linkage between birth certificates and hospital discharge birth records and with 
complete data on hospital admission and discharge dates. The study group was identified 
using International Classification of Diseases, Ninth Revision, Clinical Modification/British 
Paediatric Association (ICD-9-CM/BPA) codes 758.000, 758.020, 758.030, and 758.040 in 
MBDMP data indicating a cytogenetically confirmed diagnosis of DS. We excluded six 
children identified with DS in the MBDMP data: four were not born in a maternity hospital 
and the other two did not have a core birth certificate to hospital birth record linkage. The 
comparison group consisted of all children without a DS diagnosis to allow for an unbiased 
estimate of the impact of DS on hospital use and costs, as exclusion of children with birth 
defects from the control group would overstate the impact of DS. We excluded 5654 
children from the comparison group: 3335 not born in a maternity hospital and 2319 with no 
core linkage).
All children were classified by presence or absence of congenital heart defects (CHD) or 
other major (non-cardiac) defects (OMBD) using ICD-9-CM/BPA codes from MBDMP 
data. For children with DS and CHD, a second stage case review was performed by 
clinicians with training in cardiology. Using standard clinical nomenclature adapted from 
the Society of Thoracic Surgeons (Riehle-Colarusso et al., 2007) and a developmental 
schema, the clinicians reclassified 22 children with newborn- and prematurity-related or 
non-structural heart defects into the DS without CHD group.
2.3. Sociodemographic characteristics and birth outcomes
Birth certificates provided data on maternal race/ethnicity (NHW, NHB, and Hispanic), 
child gender, birth weight (low birthweight: <2500 g; vs. normal), gestational age (preterm: 
<37 weeks completed gestation; vs. term). Delivery payer source was based on a 
combination of data from the birth certificate and hospital discharge delivery record for the 
mother, categorized dichotomously as private insurance or not private if either record 
indicated a public payer, self-pay, or free care.
2.4. Hospital use: number of post-birth hospitalizations and days hospitalized
Hospital use was defined by number of post-birth hospitalizations (PBH) and the total 
number of days hospitalized. Birth and post-birth stay episodes were defined as the index 
hospitalization plus transfers or re-admissions to the same or to a different hospital on the 
same or next day following discharge from the index hospitalization (Weiss et al., 2009). 
The total number of PBH in an acute care hospital from 1999 to 2007 was calculated for 
children up to three years of age. Children were categorized as having 0 or ≥1 PBH.
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Number of days hospitalized was calculated by subtracting the date of admission from the 
date of discharge and adding one. Mean and median numbers of days hospitalized were 
calculated for the birth hospitalization, all PBH up to age three years, and total 
hospitalizations (Birth + PBH).
2.5. Reasons for hospitalization
The reasons that children were hospitalized were measured by tallying ICD-9-CM diagnosis 
codes across all 15 fields available for birth and post-birth hospitalizations. The primary 
diagnosis code was also examined for post-birth hospitalizations. Codes were grouped into 
the 18 Level I conditions of the Hospital Cost and Utilization Project Clinical Classification 
Software (2012) version 1.2 (2012) and then further grouped into chronic conditions related 
to the following: (1) circulatory system, (2) respiratory system, (3) digestive system, (4) 
infections/parasites, (5) neoplasms, (6) endocrine, nutritional, metabolic, immune systems, 
and (7) disorders affecting five other CCS categories of potential importance which we 
grouped due to small cell sizes: mental health, blood and blood-forming organs, the nervous 
system, the genitourinary system, and the musculoskeletal system. We did not analyze the 
remaining seven Clinical Classification Software categories for several reasons. We wanted 
to capture non-birth-defect related comorbidities, so we did not analyze congenital 
anomalies as recorded in hospital data. The remaining six categories were not something for 
which a young child could be hospitalized (e.g., complications of pregnancy; childbirth; and 
the puerperium), overly general (e.g., residual codes), and/or did not capture conditions 
particularly influential for mortality (e.g., skin/subcutaneous tissue conditions).
2.6. Data analysis
Differences in distributions of co-occurring birth defects, sociodemographic characteristics, 
and birth outcomes were examined using chi-squared tests and relative risk with 95% 
confidence intervals (CI) to make comparisons (1) between children with and without DS 
and (2) among children with DS. Between and within group comparisons of median days 
hospitalized were made using Wilcoxon rank-sums tests. Significance was defined by p ≤ .
05 for all tests. Patterns of differences in hospital use among children with DS by race/
ethnicity were then compared to patterns of differences in survival from other studies. Data 
were analyzed using SAS 9.2 (SAS Institute, Inc., Cary, NC).
2.7. Cost analysis
Costs were estimated by multiplying the total charges reported on the hospital discharge 
record with annual hospital-specific cost-to-charge ratios (including capital costs) obtained 
from the Massachusetts Division of Health Care Finance and Policy. The average cost-to-
charge ratio for all hospitalizations (birth and post-birth) in this study was 0.58, indicating 
that charges were on average almost double the estimated costs. Costs were adjusted for 
inflation to 2011 US dollars (Producer Price Index Industry Data for Hospitals; Department 
of Labor, 2012). The incremental cost of hospitalizations attributable to DS was calculated 
at the individual level as the difference between the mean costs for children with DS and for 
all other children without DS, and at the population level by multiplying that difference by 
the number of children born with DS (Amendah, Mvundura, Kavanagh, Sprinz, & Grosse, 
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2010). The mean, median and 95th percentile costs were calculated for the birth 
hospitalization, all PBH, and total birth plus PBH. PBH costs were also calculated for 
children under age one year at admission.
3. Results
There were 504 children with DS, including 21 (4.2%) children who died before age three 
years, and 468,600 children without DS, with 2119 (0.5%) deaths. The prevalence of DS in 
this study was 10.7/10,000 live births.
3.1. Hospital use
3.1.1. Number of post-birth hospitalizations (PBH)—Almost half (46.8%) of 
children with DS had one or more PBH by the age of three years, which was 4.5 times 
higher than observed for children without DS (10.4%; Table 1). The DS–nonDS risk of a 
PBH was consistently more than three times higher for all characteristics except CHD (RR 
1.1, 95% CI 1.0, 1.3) and OMBD (RR 1.1, 95% CI 0.9, 1.3).
Among children with DS, children of Hispanic mothers had a significantly higher 
percentage with a PBH (60.9%) than children of NHW mothers (44.0%), and children of 
NHB mothers had a non-significantly lower rate (39.0%; Table 1). RRs of PBH were 
significantly higher for children with CHD, OMBD, low birthweight, or preterm birth than 
those without these characteristics. Similar patterns were observed among children without 
DS, with the exception that children of NHW mothers had the lowest PBH percentage 
among the maternal racial/ethnic groups.
Among children with CHD, there were no DS–nonDS differences by race/ethnicity in PBH 
(Table 2). For children without CHD, children with DS of Hispanic or NHW mothers had 
over three-fold greater RR of PBH than children without DS in those racial/ethnic groups. 
Among children with DS, there was no racial/ethnic difference in the risk of PBH for those 
with CHD, but for those without CHD, children of Hispanic mothers had a 60% greater risk 
and children of NHB mothers had a marginally non-significant 60% lower risk of PBH 
compared to NHWs (Table 2).
3.1.2. Days hospitalized at birth and post birth to age three years—Children 
with DS had a greater mean number of days hospitalized at birth (14.7) and post-birth (8.5) 
than children without DS (4.8 and 0.7, respectively). Children with DS also had higher 
median days hospitalized at birth and in the total birth to three period than children without 
DS (birth: 7 vs. 3 days, respectively; total: 12 vs. 3 days, respectively), while post-birth 
medians were 0 for both groups (data not shown). This pattern of greater DS means and 
greater/equal DS medians was observed across all characteristics and time periods (data not 
shown), with the exception of mean post-birth days hospitalized among children with 
OMBD (DS: 11.1; non-DS: 14.8).
Among children with DS, there were significant Hispanic-NHW post-birth and total 
differences (Table 3). Privately insured children with DS had significantly fewer median 
post-birth days hospitalized than those without private insurance. Children with DS and 
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other birth defects or who were low birthweight or preterm had significantly higher birth and 
post-birth median days hospitalized than children with DS without these conditions.
Among children with CHD, there was a statistically significant 3-day difference between 
children with and without DS of NHW mothers in median days hospitalized for the total 
period (Table 4). The DS–nonDS median differences were larger but not statistically 
significant for children with CHD born to NHB and Hispanic mothers (9 and 9.5 days, 
respectively). There was a different pattern for children without CHD, where the DS–nonDS 
median differences were 15 days for Hispanics (p < 05), 5 days for NHWs (p < .05), and 3 
days for NHBs (p < .10).
Within-DS comparisons by presence of CHD revealed no racial/ethnic differences for those 
with CHDs in the birth or post-birth periods (Table 4). For the total period, children with DS 
and CHD of NHB mothers were hospitalized for significantly more days than children of 
NHW mothers. For the non-CHD group, children of Hispanic mothers had significantly 
more days hospitalized post-birth and overall compared to children of NHW mothers.
3.2. Reasons for hospitalization
The most common diagnoses at birth were infectious/parasitic conditions, affecting almost 
one third of children with DS (Table 5). Children with DS who were born to NHW mothers 
had significantly higher frequencies of infectious/parasitic comorbid diagnoses (34.8%) than 
among children with DS born to Hispanic mothers (20.3%).
Children with DS visited the hospital after birth most often for cardiovascular (22.6%), 
respiratory (31.9%), or endocrine/nutritional/metabolic/immunity (22.4%) diseases (Table 
5). Cardiovascular diseases were significantly more common among children of NHB 
mothers (34.1%) than among children of NHW mothers (21.5%). Half of children born to 
Hispanic mothers had a respiratory diagnosis, compared to 29.1% among children of NHW 
mothers (p < .01). Children with Hispanic mothers also had a significantly greater frequency 
of endocrine/nutritional/metabolic/immunity diagnoses (34.4%) compared to NHWs 
(19.8%).
3.3. Cost of hospitalizations
The total cost associated with hospitalizations from 1999 to 2007 among 504 children with 
DS was almost $20.2 million in 2011 US dollars (Table 6). Birth hospitalization costs 
totaled $10.5 million, and PBH costs totaled $9.7 million. Over half of the PBH costs 
(52.7%) were incurred prior to six months of age (data not shown). Mean incremental cost 
for children with DS vs. those without was $17,365 at birth, $18,207 post-birth, and $35,572 
total. Multiplying the mean incremental costs by the number of infants with DS, the total 
hospitalization costs attributable to DS in Massachusetts were $8.8 million and $9.2 million 
during birth and post-birth hospitalizations, respectively, for a total of $17.9 million.
Mean total hospital costs were $40,075 for children with DS, nine times higher than the 
mean for children without DS ($4503; Table 6). The $20,788 mean birth hospitalization cost 
for children with DS was higher than their $19,287 mean PBH cost. For hospitalizations 
from birth to age 1, the mean cost for children with DS was $34,069 (data not shown).
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Mean costs among children with DS varied considerably by maternal race/ethnicity. 
Children of NHB mothers had the highest mean birth hospitalization cost of $23,391, 
followed closely by children of Hispanic mothers at $22,939, and children with NHW 
mothers had the lowest mean of $20,667. In the post-birth period, children of NHB mothers 
also had the highest mean cost ($27,976), followed by Hispanics ($23,740) and NHWs 
($17,914).
Stratification by insurance type revealed lower mean birth costs but higher mean post-birth 
costs for children with DS without private insurance at delivery (Table 6). Birth 
hospitalization costs were almost two-fold greater for children with DS and CHD or OMBD 
and approximately 2.5 times greater for low birthweight or preterm compared to children 
without these conditions. Mean PBH cost differences were smaller for children with DS and 
OMBD and those born low birthweight or preterm vs. those without these conditions, but 
differences increased for CHD.
The overall median cost of hospital use per child was $15,811, over 13 times greater than 
the median for children without DS ($1188; Table 6). The birth hospitalization median cost 
for children with DS was $8589; and the post-birth median cost was $0. The median cost for 
all hospitalizations was much higher than either the birth or post-birth hospitalization 
medians due to children with high-cost birth hospitalizations and no PBH. There were 117 
children with no PBH and a birth hospital cost greater than the median (44% of the 268 
children with no PBH). Costs comparisons across maternal race/ethnicity indicated that 
children of NHB mothers had the highest birth hospitalization median cost ($10,170), but 
children of Hispanic mothers had the highest PBH median cost ($6888). The median cost 
differences across birth defects, insurance, low birthweight, and preterm birth were similar 
to the mean differences described above.
4. Discussion
This study provides statewide, population-based, longitudinal estimates of hospital use and 
cost, as well as the reasons for those hospitalizations, among infants and toddlers with DS in 
Massachusetts who were identified using birth defects registry data. Almost half of children 
with DS born in Massachusetts maternity hospitals to Massachusetts residents from 1999 to 
2004 had at least one post-birth hospitalization by the time they turned three years of age. 
Respiratory and cardiac conditions were the most common hospital-recorded PBH 
diagnoses. Roughly 90% of the total cost of all hospitalizations from birth to age three years 
in this cohort was attributable to DS and its complications. Importantly, this study provides 
novel evidence of significantly greater hospital use and cost among children of racial/ethnic 
minority mothers compared to NHW mothers, greater respiratory disease burden among 
children with Hispanic mothers, and greater cardiac disease burden among children with 
NHB mothers.
4.1. Hospital use
We found similar rates of PBH (46.8%) to those reported in a longitudinal Tennessee study, 
where 49.8% of children with DS who survived their birth hospitalization had a post-birth 
hospitalization (So et al., 2007). However, we found a lower relative risk of PBH for those 
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with vs. without CHD (RR 1.5) than reported by So and colleagues (RR 2.3; 2007). This is 
likely due largely to differences in ascertainment and CHD classification methods. So et al. 
(2007) ascertained CHDs using ICD-9-CM codes from hospital diagnoses, a method that has 
been shown to result in substantial false positive classifications (Frohnert et al., 2005), and 
all ICD-9-CM codes for cardiac defects were classified in the CHD group. We used 
ascertainment using birth defects registry data independent of hospitalization data, which is 
considered the gold standard in birth defects measurement. We further classified infants with 
non-structural and prematurity-related heart defects in the non-CHD group.
We hypothesized that maternal racial/ethnic patterns of hospital use among all children with 
DS would reveal greater NHW–NHB differential use and equivalent NHW-Hispanic use, 
corresponding to racial/ethnic patterns of survival (Day, Strauss, Shavelle, & Reynolds, 
2005; Yang et al., 2002). Our findings did not completely support this hypothesis. The 
greatest differences in both PBH and days hospitalized were observed among children of 
Hispanic vs. NHW mothers. In contrast, differences between children of NHB and NHW 
mothers were not significant or uniform in direction. Although fewer children with DS of 
NHB mothers had a PBH, they spent slightly more time in the hospital than children with 
DS of NHW mothers.
Among children with DS and CHD, we found greater hospital use for both Hispanic and 
NHB mothers relative to NHW mothers. The NHW-Hispanic difference was not consistent 
with our hypothesis, while the NHB–NHW difference was, with potential implications for 
survival. Oster, Strickland, and Mahle (2011) reported approximately 30% higher adjusted 
odds of in-hospital mortality for children with CHD with NHB vs. NHW mothers, 
controlling for presence of a genetic syndrome, such as DS, and access to care measures. 
However, another study found that infants with DS of NHB mothers had an increased risk of 
dying only if they did not have a CHD (Rasmussen et al., 2006); the investigators suggested 
that this group may have had undiagnosed CHDs or that access to care might be an issue.
The present study documented a significantly lower risk for PBH for children of NHB 
mothers with DS but no CHD compared to their NHW reference group. This could suggest 
limited access to needed care among the NHB group, a hypothesis consistent with data from 
the National Survey of Children with Special Health Care Needs. Children with DS are less 
likely to have a medical home and more likely to have unmet healthcare needs than other 
children with special health care needs (McGrath, Stransky, Cooley, & Moeschler, 2011). 
NHB children with special health care needs are also less likely to have a medical home 
(Strickland et al., 2009). A medical home is described as “a convenient reliable source for 
comprehensive care, where families are welcomed and encouraged to be involved in their 
child’s care and where comprehensive services are provided and coordinated” (Strickland et 
al., 2009, p. e996). Medical home care is considered by experts to be more effective and less 
costly (American Academy of Pediatrics, 2002). If NHB children with DS are less likely 
than their NHW counterparts to have a medical home, they might have less access to needed 
hospital care. When they do access hospital care it is more costly, as documented in this 
study, and it may be less effective. This may also have implications for disparities in 
survival.
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Greater hospital use among children with DS in the maternal Hispanic and NHB groups 
relative to the NHW group might be explained in part by greater use of prenatal diagnosis 
and elective termination among NHW women (Bishop, Huether, Torfs, Lorey, & Deddens, 
1997; Grosse, 2010; Khoshnood, Pryde, Blondel, & Lee, 2003). Lower use of prenatal 
services could result in more live births of infants with DS to NHB and Hispanic mothers. 
These infants might be more medically involved and therefore hospitalized to a greater 
extent.
Children with DS who did not have private insurance at delivery had greater post-birth 
hospital utilization than those with private insurance for both the occurrence and days 
hospitalized measures. This was similar to the pattern observed among children without DS. 
Notably, privately insured children with DS had over five-fold greater risk of PBH than 
privately insured without DS (payer status assessed at delivery). Among children without 
private insurance at delivery, those with DS had only 3.8 times greater risk of PBH 
compared to those without DS. This DS–nonDS difference for privately insured children 
was the largest among all strata of children with and without DS.
4.2. Reasons for hospitalization
More than 20% of children with DS were hospitalized post-birth for cardiovascular, 
respiratory, digestive, or endocrine/nutritional/metabolic/immunity disorders, which are 
well-documented comorbidities among this population (Hickey, Hickey, & Summar, 2012). 
Respiratory diagnoses were the most common (31.9%) followed by cardiovascular diseases 
(24.0%), which is generally consistent with other research (So et al., 2007; Thomas et al., 
2011; van Trotsenburg, Heymans, Tijssen, de Vijlder, & Vulsma, 2006; Zachariah, 
Ruttenber, & Simões, 2012). This study goes further by documenting significant differences 
by maternal race/ethnicity by comorbidity. Children with DS of Hispanic mothers were 
observed to have significantly greater respiratory, digestive, infectious/parasitic, and 
endocrine/nutritional/metabolic/immune disease burden compared to children of NHW 
mothers, while children of NHB mothers had greater post-birth cardiac disease burden. 
These results are consistent with the findings in the present study of greater hospital use 
among children with DS of Hispanic vs. NHW mothers and among children with DS and 
CHD born to NHB mothers vs. their NHW counterparts.
4.3. Cost of hospitalization
In Massachusetts from 1999 to 2004, the average cost of hospitalizations from birth to age 
three years per child with DS was $40,075 in 2011 US dollars. Slightly more than half of 
this figure ($20,788) was associated with the birth hospitalization. Eighty-five percent of 
these costs ($34,069) accrued from birth to age one year. Two recent studies on costs 
associated with hospitalizations of children with DS in the US provide estimates based on 
cross-sectional data per hospitalization rather than longitudinal data per child with DS. The 
first study reported comparable newborn/birth costs, while the second study provided much 
higher three-year estimates. The average charge per hospital stay during the newborn period, 
including birth hospitalizations, for a nationally representative cross-section of infants with 
DS was estimated by the CDC (2007) to be $38,745 in 2003. Adjusting for inflation and the 
differences in charges and costs, this translates to $19,800 in 2011. In contrast, the estimated 
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average inpatient expenditure per child with DS under age three years from a privately 
insured cross-section was $39,054 in 2011 (Boulet et al., 2008). This translates to a three-
year estimate of $117,162, which is almost 3 times higher than our estimate of $40,075. A 
similar differential in cost estimates for the same two sources of data has also been reported 
for infants with craniofacial malformations (Boulet, Grosse, Honein, & Correa, 2009; Weiss 
et al., 2009).
Novel findings indicate that overall hospital-associated costs were substantially higher for 
children with DS born to NHB or Hispanic mothers than for children born to NHW mothers. 
The mean cost for children with DS with NHB mothers was the highest among the three 
groups. However, the median cost was intermediate, reflecting the influence of a few 
outliers with high costs among the maternal NHB group. This may be attributable to 
children with DS and CHD in the maternal NHB group, who had greater hospital use than 
children with DS and CHD born to NHW mothers. The substantial difference between 
means and medians for all groups reveals the influence of small numbers of relatively high-
cost cases. The difference in mean and median costs is higher for the NHW and NHB groups 
than for the Hispanic group.
4.4. Limitations and strengths
Case ascertainment is the primary limitation for any study based on administrative data. 
Because MBDMP case ascertainment ends at age one year, we might have missed a few 
newborns with DS born in Massachusetts. Nevertheless, birth defects registry data based on 
active ascertainment are considered to be the gold standard and improve upon data from 
previous studies that use only hospital diagnoses-based ascertainment. Birth certificate and 
hospital data quality could not be verified. Birth certificate data on maternal race/ethnicity, 
birth weight, and gestational age have been shown to have good reliability (DiGiuseppe, 
Aron, Ranbom, Harper, & Rosenthal, 2002; Zollinger, Przybylski, & Gamache, 2006). 
Mother’s health insurance at delivery was measured using both birth certificate and hospital 
data to identify those with private insurance only. This variable was used in all analyses in 
order to have one consistent measure of insurance type for children with and without post-
birth hospitalizations, although mothers’ delivery insurance may differ from children’s 
health insurance for post-birth hospitalizations.
Small sample sizes, particularly among NHB children with DS, may have led to type II 
errors in comparisons with NHW children with DS. Multiple comparisons may have led to 
finding significant differences by chance. Generalizability beyond Massachusetts is limited 
by lower racial/ethnic diversity and by the widespread availability of high quality hospital 
care in Massachusetts in comparison to other states in the US.
Another limitation is the limited control for socioeconomic status. In particular, 
socioeconomic status is strongly correlated with race/ethnicity, with NHB and Hispanic 
mothers much more likely to have public delivery insurance without private health 
insurance. Although we did assess insurance status at the bivariate level in this study, the 
number of children with DS in the sample was too small to conduct a multivariable analysis.
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The longitudinal linkage rate was 82%, which means that we may have underestimated 
hospital use and costs for children whose post-birth hospital records could not be linked to 
their birth hospital records. Our data use agreement prohibits access to unlinked data needed 
for bias analyses of these factors.
Limitations of cost data include the fact that charges in hospital discharge data do not 
include physician fees, hence understating costs to some extent. Some data on hospital 
charges were missing (3.4% of records) or zero (0.2% of records). The use of average cost-
to-charge ratios to adjust charges to estimated costs also decreases precision.
The strengths of this study lie in the use of a statewide, population-based data system with 
all in-state births to residents with linkage to an active ascertainment birth defects registry 
and the reporting of data by all hospitals in the state, both of which improve upon methods 
used in existing studies. The clinical ascertainment of the presence of CHDs provides a more 
precise measure of the influence of CHDs than has been used in other studies. Finally, to our 
knowledge, this is the first published study to examine differences in hospital use and cost 
among children with DS by maternal race/ethnicity.
5. Conclusions
Patterns of hospital use from birth to age three among children with DS were found to differ 
by maternal race/ethnicity, payer source, and presence of CHD, OMBD, low birthweight, 
and preterm birth. Differences in hospital use by maternal race/ethnicity were less 
pronounced among children with DS of NHB vs. NHW mothers than among children with 
Hispanic vs. NHW mothers. Findings from this study do not support the hypothesis that 
greater hospital use in early life may signify greater morbidity among children of NHB 
mothers and explain their greater mortality rate. It is possible that the opposite is true, that 
infants with DS born to NHB mothers are not accessing needed medical care, which leads to 
greater mortality. More research is needed, particularly on the severity of CHD among 
children with DS across maternal racial/ethnic groups, and on the medical conditions of 
those without CHD in order to better understand the how hospital use may illuminate 
mechanisms behind survival disparities.
Our study documents the burden of health problems among children with DS of Hispanic 
mothers and among children with DS and CHD of NHB mothers, relative to children with 
DS of NHW mothers. Targeted secondary prevention efforts, for example, focusing on the 
prevention and management of respiratory disorders among Hispanic families of children 
with DS, might reduce these disparities as has been shown for other pediatric conditions. For 
example, an asthma management program targeted to urban minority children has been 
show to substantially reduce the elevated rates of preventable hospitalization among NHB 
and Hispanic children (Cloutier, Jones, Hinckson, & Wakefield, 2008). Findings of lower 
post-birth hospital use among children with DS born to NHB mothers but no CHD relative 
to children born to NHW mothers suggests the possibility that the former group has less 
optimal access to needed care. If this hypothesis is confirmed in future studies, improving 
systems of care may be one avenue to address racial/ethnic disparities in morbidity and 
mortality among people with DS.tpb 9pt
Derrington et al. Page 12














We thank the following PELL Down Syndrome Project Team members who provided their guidance to the overall 
project: Hafsatou Diop, Marlene Anderka, and Susan Manning of the Massachusetts Department of Public Health; 
Sheree Boulet, Suzanne Gilboa, and Sonja Rasmussen of the Centers for Disease Control and Prevention; and 
Manjusha Gokhale, Daksha Gopal, Qi Yu and Eugene Declercq of the Boston University School of Public Health. 
In particular, we thank Cathleen Higgins, Birth Defects Surveillance Coordinator, from the Massachusetts Birth 
Defect Monitoring Program for her work providing data and assisting with classifications of birth defects among 
children with DS. Funding for this study came from Contract No. 200-2007-22997 from the National Centers on 
Birth Defects and Developmental Disabilities and for Chronic Disease Prevention and Health Promotion of the 
Centers for Disease Control and Prevention.
PELL is a university-government partnership between the Boston University School of Public Health, the 
Massachusetts Department of Public Health, and the Centers for Disease Control and Prevention (CDC) and was 
funded by the CDC (PELL Data System Expansion and Associated Analyses Contract No. 200-2009-31671). The 
findings and conclusions in this report are those of the authors and do not necessarily represent the official position 
of the Centers for Disease Control and Prevention or the Massachusetts Department of Public Health.
References
Amendah DD, Mvundura M, Kavanagh PL, Sprinz PG, Grosse SD. Sickle cell disease-related 
pediatric medical expenditures in the U.S. American Journal of Preventive Medicine. 2010; 
38:S550–S556. [PubMed: 20331957] 
Academy of Pediatrics. Policy statement: Medical Home Initiatives for Children With Special Needs 
Project Advisory Committee – The Medical Home. Pediatrics. 2002; 110:184–186. [PubMed: 
12093969] 
Ash M, Brandt S. Disparities in asthma hospitalization in Massachusetts. American Journal of Public 
Health. 2006; 96:358–362. [PubMed: 16380574] 
Bishop J, Huether CA, Torfs C, Lorey F, Deddens J. Epidemiologic study of Down syndrome in a 
racially diverse California population, 1989–1991. American Journal of Epidemiology. 1997; 
145:134–147. [PubMed: 9006310] 
Boulet SL, Grosse SD, Honein MA, Correa A. Children with orofacial clefts: Health care use and costs 
among a privately insured population. Public Health Reports. 2009; 124:447–453. [PubMed: 
19445422] 
Boulet SL, Molinari N, Grosse SD, Honein MA, Correa A. Health care expenditures for infants and 
young children with Down syndrome in a privately insured population. Journal of Pediatrics. 2008; 
153:241–246. [PubMed: 18534234] 
Centers for Disease Control and Prevention. Racial disparities in median age at death of persons with 
Down syndrome – United States, 1968–1997. MMWR – Morbidity & Mortality Weekly Report. 
2001; 50:463–465. [PubMed: 11414598] 
Centers for Disease Control and Prevention. Hospital stays, hospital charges, and in-hospital deaths 
among infants with selected birth defects – United States, 2003. MMWR – Morbidity & Mortality 
Weekly Report. 2007; 56:25–29. [PubMed: 17230142] 
Cleves MA, Hobbs CA, Cleves PA, Tilford JM, Bird TM, Robbins JM. Congenital defects among 
liveborn infants with Down syndrome. Birth Defects Research Part A: Clinical and Molecular 
Teratology. 2007; 79:657–663.
Cloutier MM, Jones GA, Hinckson V, Wakefield DB. Effectiveness of an asthma management 
program in reducing disparities in care in urban children. Annals of Allergy, Asthma and 
Immunology. 2008; 100:545–550.
Crocker D, Brown C, Moolenaar R, Moorman J, Bailey C, Mannino D, et al. Racial and ethnic 
disparities in asthma medication usage and health-care utilization: Data from the National Asthma 
Survey. Chest. 2009; 136:1063–1071. [PubMed: 19567492] 
Day SM, Strauss DJ, Shavelle RM, Reynolds RJ. Mortality and causes of death in persons with Down 
syndrome in California. Developmental Medicine and Child Neurology. 2005; 47:171–176. 
[PubMed: 15739721] 
Derrington et al. Page 13













Declercq E, Barger M, Cabral HJ, Evans SE, Kotelchuck M, Simon C, et al. Maternal outcomes 
associated with planned primary cesarean births compared with planned vaginal births. Obstetrics 
and Gynecology. 2007; 109:669–677. [PubMed: 17329519] 
DiGiuseppe DL, Aron DC, Ranbom L, Harper DL, Rosenthal GE. Reliability of birth certificate data: 
A multi-hospital comparison to medical records information. Maternal and Child Health Journal. 
2002; 6:169–179. [PubMed: 12236664] 
Erickson SE, Iribarren C, Tolstykh IV, Blanc PD, Eisner MD. Effect of race on asthma management 
and outcomes in a large, integrated managed care organization. Archives of Internal Medicine. 
2007; 167:1846–1852. [PubMed: 17893305] 
Frohnert BK, Lussky RC, Alms MA, Mendelsohn NJ, Symonik DM, Falken MC. Validity of hospital 
discharge data for identifying infants with cardiac defects. Journal of Perinatology. 2005; 25:737–
742. [PubMed: 16163368] 
Grosse, SD. Sociodemographic characteristics of families of children with Down syndrome and the 
economic impacts on families of child disability. In: Urbano, R., editor. Health issues in persons 
with Down syndrome. Vol. Vol. 39. Elsevier Inc. Academic Press; San Diego, CA: 2010. p. 
257-294.
Healthcare Cost and Utilization Project (HCUP). Clinical Classifications Software (CCS) for ICD-9-
CM [Computer Software]. Agency for Healthcare Research and Quality; Rockville, MD: 2012. 
Hickey F, Hickey E, Summar KL. Medical update for children with down syndrome for the 
pediatrician and family practitioner. Advances in Pediatrics. 2012; 59:137–157. [PubMed: 
22789577] 
Jones R, Lin S, Munsie JP, Radigan M, Hwang SA. Racial/ethnic differences in asthma-related 
emergency department visits and hospitalizations among children with wheeze in Buffalo, New 
York. Journal of Asthma. 2008; 45:916–922. [PubMed: 19085583] 
Khoshnood B, Pryde P, Blondel B, Lee KS. Socioeconomic and state-level differences in prenatal 
diagnosis and live birth prevalence of Down’s syndrome in the United States. Revue 
d’épidémiologie et de Santé Publique. 2003; 51:617–627.
Laditka JN, Laditka SB. Race, ethnicity and hospitalization for six chronic ambulatory care sensitive 
conditions in the USA. Ethnicity and Health. 2006; 11:247–263. [PubMed: 16774877] 
Lu S, Kuo DZ. Hospital charges of potentially preventable pediatric hospitalizations. Academic 
Pediatrics. 2012; 12:436–444. [PubMed: 22922047] 
Lynberg, MC.; Edmonds, LD. Surveillance of birth defects. In: Halperin, W.; Baker, ER., editors. 
Public health surveillance. Van Nostrand Reinhold; New York, NY: 1992. p. 157-177.
McGrath RJ, Stransky ML, Cooley WC, Moeschler JB. National profile of children with down 
syndrome: Disease burden, access to care, and family impact. The Journal of Pediatrics. 2011; 
159(535–540):e532.
Oster ME, Strickland MJ, Mahle WT. Racial and ethnic disparities in post-operative mortality 
following congenital heart surgery. The Journal of Pediatrics. 2011; 159:222–226. [PubMed: 
21414631] 
Rasmussen SA, Whitehead N, Collier SA, Frías JL. Setting a public health research agenda for Down 
syndrome: Summary of a meeting sponsored by the Centers for Disease Control and Prevention 
and the National Down Syndrome Society. American Journal of Medical Genetics Part A. 2008; 
146A:2998–3010. [PubMed: 19006076] 
Rasmussen SA, Wong L-Y, Correa A, Gambrell D, Friedman JM. Survival in infants with Down 
syndrome, Metropolitan Atlanta, 1979–1998. The Journal of Pediatrics. 2006; 148(806–812):e801.
Riehle-Colarusso T, Strickland M, Reller M, Mahle W, Botto L, Siffel C, et al. Improving the quality 
of surveillance data on congenital heart defects in the metropolitan Atlanta congenital defects 
program. Birth Defects Research Part A: Clinical and Molecular Teratology. 2007; 79:743–753.
Roy SR, McGinty EE, Hayes SC, Zhang L. Regional and racial disparities in asthma hospitalizations 
in Mississippi. Journal of Allergy and Clinical Immunology. 2010; 125:636–642. [PubMed: 
20226297] 
Russo, CA.; Elixhauser, A. Hospitalizations for birth defects, 2004. US Agency for Healthcare 
Research and Quality (AHRQ); Rockville, MD: 2007. HCUP Statistical Brief #24
Derrington et al. Page 14













So SA, Urbano RC, Hodapp RM. Hospitalizations of infants and young children with Down 
syndrome: Evidence from inpatient person-records from a statewide administrative database. 
Journal of Intellectual Disability Research. 2007; 51:1030–1038. [PubMed: 17991010] 
Strickland BB, Singh GK, Kogan MD, Mann MY, van Dyck PC, Newacheck PW. Access to the 
Medical Home: New Findings From the 2005–2006 National Survey of Children With Special 
Health Care Needs. Pediatrics. 2009; 123:e996–e1004. [PubMed: 19482751] 
Thomas K, Bourke J, Girdler S, Bebbington A, Jacoby P, Leonard H. Variation over time in medical 
conditions and health service utilization of children with down syndrome. The Journal of 
Pediatrics. 2011; 158(194–200):e191.
Torfs CP, Christianson RE. Anomalies in Down syndrome individuals in a large population-based 
registry. American Journal of Medical Genetics. 1998; 77:431–438. [PubMed: 9632176] 
van Trotsenburg ASP, Heymans HSA, Tijssen JGP, de Vijlder JJM, Vulsma T. Comorbidity, 
hospitalization and medication use and their influence on mental and motor development of young 
infants with Down syndrome. Pediatrics. 2006; 118:1633–1639. [PubMed: 17015556] 
Weiss J, Kotelchuck M, Grosse SD, Manning SE, Anderka M, Wyszynski DF, et al. Hospital use and 
associated costs of children aged zero-to-two years with craniofacial malformations in 
Massachusetts. Birth Defects Research Part A: Clinical and Molecular Teratology. 2009; 85:925–
934.
Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down’s syndrome in the USA from 
1983 to 1997: A population-based study. The Lancet. 2002; 359:1019–1025.
Zachariah P, Ruttenber M, Simões EAF. Down syndrome and hospitalizations due to respiratory 
syncytial virus: A population-based study. The Journal of Pediatrics. 2012; 160(827–831):e821.
Zollinger TW, Przybylski MJ, Gamache RE. Reliability of Indiana birth certificate data compared to 
medical records. Annals of Epidemiology. 2006; 16:1–10. [PubMed: 16039875] 
Derrington et al. Page 15








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Derrington et al. Page 19
Table 3
Mean and median number of days hospitalized per child with Down syndrome (DS) from birth to age three 
years by sociodemographic characteristics, major birth defects and birth outcomes, Massachusetts.a
N
No. of days hospitalized
at birthb
No. of days hospitalized
post-birthc
No. of days hospitalized at
birth & post-birth
Mean Median Mean Median Mean Median
All Children 504 14.7 7.0 8.5 0.0 23.0 12.0
Race/ethnicity
 NHB 41 16.6 8.0 8.8 0.0 25.4 12.0
 Hispanic 64 20.3 8.5 15.7 5.0 36.0 20.0
 NHW 368 13.8 7.0 7.3 0.0 21.1 11.0
Delivery payer source
 Not Private 154 15.2 7.0 12.2 2.0 27.4 14.0
 Private 350 14.5 7.0 6.9 0.0 21.4 12.0
Sex
 Male 277 15.5 8.0 8.9 2.0 24.3 14.0
 Female 227 13.8 7.0 8.1 0.0 21.8 10.0
CHD
 Yes 219 18.0 9.0 12.3 5.0 30.3 17.0
 No 285 12.2 6.0 5.6 0.0 17.7 9.0
OMBD
 Yes 77 24.1 16.0 11.1 4.0 35.2 24.0
 No 427 13.0 7.0 8.0 0.0 21.0 11.0
LBW
 Yes 105 29.2 18.0 11.3 3.0 40.6 29.0
 No 394 10.9 6.0 7.8 0.0 18.6 10.0
PTB
 Yes 127 26.0 15.0 10.6 3.0 36.6 23.0
 No 373 10.8 6.0 7.8 0.0 18.6 10.0
Note: Boldface figures indicate significant Wilcoxon rank sum test (p < .05) differences among children with DS across characteristics.
Abbreviations: CHD, congenital heart defects; LBW, low birth weight (<2500 g); NHB, Non-Hispanic Black; NHW, Non-Hispanic White; 
OMBD, other major (non-cardiac) birth defects; PTB, preterm birth < 37 weeks completed gestation; ref., reference group.
a
Births from 1999 to 2004, hospitalizations from 1999 to 2007.
b
Birth hospitalizations include children who were readmitted or transferred to another acute care hospital <2 days following discharge from their 
initial birth hospitalization, as well as children readmitted <2 days following discharge from the transfer hospital.
c
Up to age three years.
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Table 5
Differences by maternal race/ethnicity in reasons for hospitalization from birth to age three years among 
children with Down syndrome (DS), Massachusetts hospitalizations 1999–2007.
N Birth Post birth Post birth
All diagnoses All diagnoses Primary diagnoses
n % n % n %
Diseases of the cardiovascular system 504 34 6.7 114 22.6 22 4.4
 Non-Hispanic Black 41 4 9.8 14 34.1 * 4 9.8†
 Hispanic 64 5 7.8 15 23.4 4 6.3
 Non-Hispanic White 368 23 6.3 79 21.5 12 3.3
Diseases of the respiratory system 504 15 3.0 161 31.9 122 24.2
 Non-Hispanic Black 41 0 0.0 11 26.8 6 14.6
 Hispanic 64 2 3.1 32 50.0 ** 29 45.3 **
 Non-Hispanic White 368 12 3.3 107 29.1 78 21.2
Diseases of the digestive system 504 27 5.4 108 21.4 29 5.8
 Non-Hispanic Black 41 1 2.4 7 17.1 1 2.4
 Hispanic 64 7 10.9† 21 32.8†,a 6 9.4
 Non-Hispanic White 368 18 4.9 71 19.3 21 5.7
Infectious and parasitic diseases 504 166 32.9 85 16.9 13 2.6
 Non-Hispanic Black 41 12 29.3 9 22.0 1 2.4
 Hispanic 64 13 20.3 * 15 23.4 2 3.1
 Non-Hispanic White 368 128 34.8 54 14.7 7 1.9
Endocrine; nutritional; and metabolic diseases
 and immunity disorders
504 18 3.6 113 22.4 35 6.9
 Non-Hispanic Black 41 0 0.0 10 24.4 3 7.3
 Hispanic 64 3 4.7 22 34.4 * 6 9.4
 Non-Hispanic White 368 13 3.5 73 19.8 22 6.0
Note: Boldface figures highlight statistically significant comparisons.
a
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